1. Liu ZM, Ho SC, Chen YM, Woo J. A six-month randomized controlled trial of whole soy and isoflavones daidzein on body composition in equol-producing postmenopausal women with prehypertension. J Obes. 2013; 2013:359763.
2. Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, et al. Differential expression of factors involved in fat metabolism with age and the menopause transition. Maturitas. 2005; 51:299–306.
3. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Post-menopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 1991; 40:1323–1326.
4. Sørensen MB, Rosenfalck AM, Højgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res. 2001; 9:622–626.
5. Björn I, Bäcksröm T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas. 1999; 32:77–86.
6. Rahimi R, Ardekani MR. Medicinal properties of Foeniculum vulgare Mill. In traditional Iranian medicine and modern phytotherapy. Chin J Integr Med. 2013; 19:73–79.
7. Hur MH, Kim C, Kim CH, Ahn HC, Ahn HY. The effects of inhalation of essential oils on the body weight, food efficiency rate and serum leptin of growing SD rats. J Korean Acad Nurs. 2006; 36:236–243.
8. Bae J, Kim J, Choue R, Lim H. Fennel (Foeniculum vulgare) and Fenugreek (Trigonella foenum-graecum) tea drinking suppresses subjective short-term appetite in overweight women. Clin Nutr Res. 2015; 4:168–174.
9. Kim SJ, Kim KS, Shin SU, Choi YM, Kang BG, Yoon YS, et al. A clinical study of decrease appetite effects by aromatherapy using foeniculum vulgare mill (fennel) to female obese patients. J Korean Orient Assoc Stud Obes. 2005; 5:9–20.
10. Puska P, Korpelainen V, Høie LH, Skovlund E, Smerud KT. Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholesterolaemia: a double-blind, placebo-controlled trial of a yoghurt formulation. Br J Nutr. 2004; 91:393–401.
11. Arjmandi BH, Lucas EA, Khalil DA, Devareddy L, Smith BJ, McDonald J, et al. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J. 2005; 4:8.
12. Sites CK, Cooper BC, Toth MJ, Gastaldelli A, Arabshahi A, Barnes S. Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril. 2007; 88:1609–1617.
13. Garrido A, De la, Hirsch S, Valladares L. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women. Maturitas. 2006; 54:270–276.
14. Weickert MO, Reimann M, Otto B, Hall WL, Vafeiadou K, Hallund J, et al. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. J Negat Results Biomed. 2006; 5:11.
15. Zhang YB, Chen WH, Guo JJ, Fu ZH, Yi C, Zhang M, et al. Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women-a meta-analysis. Nutrition. 2013; 29:8–14.
16. Machado AM, de Paula H, Cardoso LD, Costa NM. Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents. Nutrition. 2015; 31:90–96.